comparemela.com
Home
Live Updates
CytoMed Therapeutics Announces China Research Collaboration
CytoMed Therapeutics Announces China Research Collaboration
CytoMed Therapeutics Announces China Research Collaboration to Enhance its Allogeneic CAR γδ T In Vivo Persistency
/PRNewswire/ -- CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or "Company"), a Singapore-based biopharmaceutical company focused on harnessing its...
Related Keywords
Singapore ,
Zhejiang ,
China ,
Lu Shan ,
Henan ,
Hangzhou ,
Wang Shu ,
Hebei ,
Peter Choo ,
Linkedin ,
Facebook ,
Cytomed Scientific Advisory Committee ,
National Development ,
Therapeutics Co Ltd ,
Agency For Science ,
Cytomed Therapeutics Limited ,
Cytomed Or Company ,
Foreign Affairs Sim Ann ,
Council Meeting ,
Prnewswire Cytomed Therapeutics Limited ,
Med Therapeutics Limited ,
Chimeric Antigen Receptor ,
Tan Wee Kiat ,
Chief Operating Officer ,
Professor Wang Shu ,
Singapore Zhejiang Economic ,
Trade Council ,
Senior Minister ,